News

Veranova’s Devens Site Successfully Passes FDA Inspection with Zero Observations

Veranova Appoints Thomas Rohrer as Vice President of Bioconjugation

SCALE 2025: A Celebration of Scientific Innovation and Collaboration in Pharma

Veranova Appoints Dr. Matteo Villain as Vice President of Peptides and Oligonucleotides

Veranova Devens Site Breaks Ground on ADC Facility Expansion

Veranova Announces Strategic Investment to Establish cGMP Bioconjugation Capability in Devens, MA

Veranova Awarded EcoVadis Bronze Rating for Sustainability Efforts

Veranova Appoints Elizabeth Rebeil as Global Vice President of Supply Chain and Operational Excellence

Veranova Expands Advisory Board with Appointment of Dr. Marvin H. Caruthers

Veranova Hosts Second Cambridge Science Day

Veranova Welcomes Dr. Scott Zugel as Global VP of Analytical Research Development Operations

Veranova honors its inspiring women on International Day for Women and Girls in Science

Industry Roundtable: Small-Molecule APIs

Veranova Releases New Video Showcasing Extensive Technical Capabilities and Expertise

Join us at Fierce JPM Week!

HPAPI for Drug Development and Delivery

An interview with Veranova’s CCO, Cécile Maupas and CTO, Rohtash Kumar

Veranova Recognized as One of SOCMA’s 25 Companies with Industry-Leading Safety Programs

Veranova announces Cécile Maupas Now Directly Responsible for Bitrex Commercial Operations, Strengthening Veranova’s Commitment to Safety and Innovation

Veranova Expands Advisory Board with Appointment of Dr. Rajni Aneja and Dr. Bradley L. Pentelute

Nutriband Licenses Bitrex® Brand Aversive Agent for Its Lead Product – AVERSA™ Fentanyl Transdermal Patch

The Evolution of the CDMO Industry

Veranova Appoints Mayya Buffington as Vice President, Chief Information Officer

Veranova Appoints Cécile Maupas as Senior Vice President, Chief Commercial Officer

Veranova CEO, Mike Riley, discusses the transition from chemicals to CDMO

Veranova Continues Strategic Expansion with the Appointment of Ryan Raymond as Vice President, Global Controller

Veranova Announces New Investment to Expand ADC and Highly Potent API Capabilities at Devens, MA, Facility

ADCs and their Drug Development Process

An interview with Veranova’s CEO, Mike Riley

Veranova and Phorum.AI Partner to Deliver Generative AI Chemistry Optimization to the Pharmaceutical and Biotech Industry

Harnessing the Power of Solid Form and Particle Engineering to Overcome Solubility and Bioavailability Challenges

Veranova CEO Mike Riley Recognized in The Medicine Maker’s Power List 2024

Veranova Strengthens Senior Leadership Team with Appointment of Scott Lassonde as SVP, Chief Financial Officer

Veranova Celebrates International Women’s Day 2024

Veranova Hosts First Annual Veranova Chemistry and Technology Meeting (VCTM)

Veranova Strengthens Engineering Leadership with Appointment of Chris Holmes as Vice President, Global Engineering

Introducing Veranova’s Advisory Board

Veranova Strengthens Leadership Further by Welcoming Lucas Sauer-Jones as Vice President & General Manager, New England

In Conversation with Mike Riley, CEO of Veranova

Kishore Hotha Joins Chemistry Today’s Scientific Advisory Board

Realizing The Potential of Antibody-Drug Conjugates

Jose Ibietatorremendia to Join Veranova as SVP, General Counsel, and Secretary

Veranova Recognized as One of SOCMA’s 12 Companies for Industry-Leading Safety Programs

Veranova Expands Contract Expertise

The Evolving Role of Outsourcing in Pharmaceutical Development

Investing For The Future

Veranova Announces Appointment of New Advisory Board

Veranova Welcomes Dr. William Sanders as Global VP of Chemical Development Operations

Veranova at CPHI Barcelona

Veranova Strengthens Leadership Team: Victoria Brown Joins as SVP, Chief HR Officer

Testing Innovative Analytical Waters

Managing complexity with confidence: Q&A with Veranova CEO Mike Riley

Veranova celebrates the 20th anniversary of Pharmorphix®

Veranova celebrates first year as an independent CDMO

Dr. Rohtash Kumar joins Veranova as Chief Technology Officer

Solubility – meeting the challenge

Veranova appoints Mike Riley as Chief Executive Officer

Veranova proposes closure of Annan facility

Celebrating Veranova’s women in science

Veranova completes mid-scale API expansion at Edinburgh, UK facility

In conversation with Niek Stapel, CEO of Veranova

How can today’s CDMOs ensure they can meet tomorrow’s demands?

Leading the way in Synthetic Chemistry

Veranova at CPHI WW

JM Health rebrands as Veranova following sale to Altaris Capital Partners

Cookie	Duration	Description
cookielawinfo-checkbox-advertisement	1 year	Set by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Advertisement" category .
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Cookie	Duration	Description
bcookie	2 years	LinkedIn sets this cookie from LinkedIn share buttons and ad tags to recognize browser ID.
bscookie	2 years	LinkedIn sets this cookie to store performed actions on the website.
lang	session	LinkedIn sets this cookie to remember a user's language setting.
lidc	1 day	LinkedIn sets the lidc cookie to facilitate data center selection.
UserMatchHistory	1 month	LinkedIn sets this cookie for LinkedIn Ads ID syncing.

Cookie	Duration	Description
_ga	2 years	The _ga cookie, installed by Google Analytics, calculates visitor, session and campaign data and also keeps track of site usage for the site's analytics report. The cookie stores information anonymously and assigns a randomly generated number to recognize unique visitors.
_ga_93SR2NP051	2 years	This cookie is installed by Google Analytics.
_gat_UA-229184347-1	1 minute	A variation of the _gat cookie set by Google Analytics and Google Tag Manager to allow website owners to track visitor behaviour and measure site performance. The pattern element in the name contains the unique identity number of the account or website it relates to.
_gcl_au	3 months	Provided by Google Tag Manager to experiment advertisement efficiency of websites using their services.
_gid	1 day	Installed by Google Analytics, _gid cookie stores information on how visitors use a website, while also creating an analytics report of the website's performance. Some of the data that are collected include the number of visitors, their source, and the pages they visit anonymously.
CONSENT	2 years	YouTube sets this cookie via embedded youtube-videos and registers anonymous statistical data.

Cookie	Duration	Description
test_cookie	15 minutes	The test_cookie is set by doubleclick.net and is used to determine if the user's browser supports cookies.
VISITOR_INFO1_LIVE	5 months 27 days	A cookie set by YouTube to measure bandwidth that determines whether the user gets the new or old player interface.
YSC	session	YSC cookie is set by Youtube and is used to track the views of embedded videos on Youtube pages.
yt-remote-connected-devices	never	YouTube sets this cookie to store the video preferences of the user using embedded YouTube video.
yt-remote-device-id	never	YouTube sets this cookie to store the video preferences of the user using embedded YouTube video.

Cookie	Duration	Description
AnalyticsSyncHistory	1 month	No description
li_gc	2 years	No description

Veranova’s Devens Site Successfully Passes FDA Inspection with Zero Observations

Veranova Appoints Thomas Rohrer as Vice President of Bioconjugation

SCALE 2025: A Celebration of Scientific Innovation and Collaboration in Pharma

Veranova Appoints Dr. Matteo Villain as Vice President of Peptides and Oligonucleotides

Veranova Devens Site Breaks Ground on ADC Facility Expansion

Veranova Announces Strategic Investment to Establish cGMP Bioconjugation Capability in Devens, MA

Veranova Awarded EcoVadis Bronze Rating for Sustainability Efforts

Veranova Appoints Elizabeth Rebeil as Global Vice President of Supply Chain and Operational Excellence

Veranova Expands Advisory Board with Appointment of Dr. Marvin H. Caruthers

Veranova Hosts Second Cambridge Science Day

Veranova Welcomes Dr. Scott Zugel as Global VP of Analytical Research Development Operations

Join us at the ADC Analytical Development Summit!

Veranova Relocates Headquarters to Devens, MA

Join us at World ADC, London!

Veranova honors its inspiring women on International Day for Women and Girls in Science

Industry Roundtable: Small-Molecule APIs

Veranova Releases New Video Showcasing Extensive Technical Capabilities and Expertise

Join us at Fierce JPM Week!

HPAPI for Drug Development and Delivery

An interview with Veranova’s CCO, Cécile Maupas and CTO, Rohtash Kumar

Veranova Recognized as One of SOCMA’s 25 Companies with Industry-Leading Safety Programs

Veranova announces Cécile Maupas Now Directly Responsible for Bitrex Commercial Operations, Strengthening Veranova’s Commitment to Safety and Innovation

Veranova Expands Advisory Board with Appointment of Dr. Rajni Aneja and Dr. Bradley L. Pentelute

Nutriband Licenses Bitrex® Brand Aversive Agent for Its Lead Product – AVERSA™ Fentanyl Transdermal Patch

The Evolution of the CDMO Industry

Veranova Appoints Mayya Buffington as Vice President, Chief Information Officer

Veranova Appoints Cécile Maupas as Senior Vice President, Chief Commercial Officer

Veranova CEO, Mike Riley, discusses the transition from chemicals to CDMO

Veranova Continues Strategic Expansion with the Appointment of Ryan Raymond as Vice President, Global Controller

Veranova Announces New Investment to Expand ADC and Highly Potent API Capabilities at Devens, MA, Facility

ADCs and their Drug Development Process

An interview with Veranova’s CEO, Mike Riley

Veranova and Phorum.AI Partner to Deliver Generative AI Chemistry Optimization to the Pharmaceutical and Biotech Industry

Harnessing the Power of Solid Form and Particle Engineering to Overcome Solubility and Bioavailability Challenges

Veranova CEO Mike Riley Recognized in The Medicine Maker’s Power List 2024

Veranova Strengthens Senior Leadership Team with Appointment of Scott Lassonde as SVP, Chief Financial Officer

Veranova Celebrates International Women’s Day 2024

Veranova Hosts First Annual Veranova Chemistry and Technology Meeting (VCTM)

Veranova Strengthens Engineering Leadership with Appointment of Chris Holmes as Vice President, Global Engineering

Introducing Veranova’s Advisory Board

Veranova Strengthens Leadership Further by Welcoming Lucas Sauer-Jones as Vice President & General Manager, New England

In Conversation with Mike Riley, CEO of Veranova

Kishore Hotha Joins Chemistry Today’s Scientific Advisory Board

Realizing The Potential of Antibody-Drug Conjugates

Jose Ibietatorremendia to Join Veranova as SVP, General Counsel, and Secretary

Veranova Recognized as One of SOCMA’s 12 Companies for Industry-Leading Safety Programs

Veranova Expands Contract Expertise

The Evolving Role of Outsourcing in Pharmaceutical Development

Investing For The Future

Veranova Announces Appointment of New Advisory Board

Veranova Welcomes Dr. William Sanders as Global VP of Chemical Development Operations

Veranova at CPHI Barcelona

Veranova Strengthens Leadership Team: Victoria Brown Joins as SVP, Chief HR Officer

Testing Innovative Analytical Waters

Managing complexity with confidence: Q&A with Veranova CEO Mike Riley

Veranova celebrates the 20th anniversary of Pharmorphix®

Veranova celebrates first year as an independent CDMO

Dr. Rohtash Kumar joins Veranova as Chief Technology Officer

Solubility – meeting the challenge

Veranova appoints Mike Riley as Chief Executive Officer

Veranova proposes closure of Annan facility

Celebrating Veranova’s women in science

Veranova completes mid-scale API expansion at Edinburgh, UK facility

In conversation with Niek Stapel, CEO of Veranova

How can today’s CDMOs ensure they can meet tomorrow’s demands?

Leading the way in Synthetic Chemistry

Veranova at CPHI WW

JM Health rebrands as Veranova following sale to Altaris Capital Partners

Featured insights from our experts

Antibody-drug conjugate development: challenges and opportunities

Understanding the formation of cocrystals

Continuous manufacturing (flow chemistry) - the future of pharmaceutical manufacturing

Veranova is your next great decision